{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:33:34Z","timestamp":1791923614102,"version":"4.3.4"},"reference-count":70,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Citicoline is a chemical compound involved in the synthesis of cell membranes. It also has other, not yet explained functions. Research on the use of citicoline is conducted in neurology, ophthalmology, and psychiatry. Citicoline is widely available as a dietary supplement. It is often used to enhance cognitive functions. In our article, accessible databases were searched for articles regarding citicoline use in neurological diseases. This article has a systemic review form. After rejecting non-eligible reports, 47 remaining articles were reviewed. The review found that citicoline has been proven to be a useful compound in preventing dementia progression. It also enhances cognitive functions among healthy individuals and improves prognosis after stroke. In an animal model of nerve damage and neuropathy, citicoline stimulated regeneration and lessened pain. Among patients who underwent brain trauma, citicoline has an unclear clinical effect. Citicoline has a wide range of effects and could be an essential substance in the treatment of many neurological diseases. Its positive impact on learning and cognitive functions among the healthy population is also worth noting.<\/jats:p>","DOI":"10.3390\/nu12103113","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T22:02:02Z","timestamp":1602626522000},"page":"3113","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Application of Citicoline in Neurological Disorders: A Systematic Review"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0958-735X","authenticated-orcid":false,"given":"Patryk","family":"Jasielski","sequence":"first","affiliation":[{"name":"Department of Neurology, Medical University of Lublin, 20-059 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faustyna","family":"Pi\u0119del","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Lublin, 20-059 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miko\u0142aj","family":"Piwek","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Lublin, 20-059 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Rocka","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Lublin, 20-059 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Petit","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Lublin, 20-059 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7019-6681","authenticated-orcid":false,"given":"Konrad","family":"Rejdak","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Lublin, 20-059 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.22336\/rjo.2017.29","article-title":"Citicoline\u2014A neuroprotector with proven effects on glaucomatous disease","volume":"61","author":"Iulia","year":"2017","journal-title":"Romanian J. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WNF.0000000000000185","article-title":"Citicoline Combination Therapy for Major Depressive Disorder","volume":"40","author":"Arabzadeh","year":"2017","journal-title":"Clin. Neuropharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40263-014-0144-8","article-title":"Neuroprotective properties of citicoline: Facts, doubts and unresolved issues","volume":"28","author":"Grieb","year":"2014","journal-title":"Cns Drugs"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.neuron.2014.01.028","article-title":"SIRT1 in Neurodevelopment and Brain Senescence","volume":"81","author":"Herskovits","year":"2014","journal-title":"Neuron"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3389\/fendo.2018.00702","article-title":"Brain SIRT1 Mediates Metabolic Homeostasis and Neuroprotection","volume":"9","author":"Xu","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1474-4422(11)70013-8","article-title":"The sirtuin pathway in ageing and Alzheimer disease: Mechanistic and therapeutic considerations","volume":"10","author":"Bonda","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1523\/JNEUROSCI.3442-11.2012","article-title":"SIRT1 protects against \u03b1-synuclein aggregation by activating molecular chaperones","volume":"32","author":"Donmez","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/jnc.12269","article-title":"Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke","volume":"126","author":"Hurtado","year":"2013","journal-title":"J. Neurochem."},{"key":"ref_9","first-page":"S1","article-title":"Citicoline: Pharmacological and clinical review, 2016 update","volume":"63","author":"Secades","year":"2016","journal-title":"Rev. De Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Synoradzki, K., and Grieb, P. (2019). Citicoline: A Superior Form of Choline?. Nutrients, 11.","DOI":"10.3390\/nu11071569"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Blusztajn, J.K., Slack, B.E., and Mellott, T.J. (2017). Neuroprotective Actions of Dietary Choline. Nutrients, 9.","DOI":"10.3390\/nu9080815"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.physbeh.2018.08.002","article-title":"Influence of citicoline on citalopram-induced antidepressant activity in depressive-like symptoms in male mice","volume":"195","author":"Akhondzadeh","year":"2018","journal-title":"Physiol. Behav."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.nbd.2004.10.006","article-title":"Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: Effects on glutamate transport","volume":"18","author":"Hurtado","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/01616412.1995.11740327","article-title":"Citicoline (CDP-Choline): Mechanisms of action and effects in ischemic brain injury","volume":"17","author":"Sandage","year":"1995","journal-title":"Neurol. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00213-002-1045-y","article-title":"Chronic citicoline increases phosphodiesters in the brains of healthy older subjects: An in vivo phosphorus magnetic resonance spectroscopy study","volume":"161","author":"Babb","year":"2002","journal-title":"Psychopharmacol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.0022-3042.2001.00697.x","article-title":"Citicoline: Neuroprotective mechanisms in cerebral ischemia","volume":"80","author":"Adibhatla","year":"2002","journal-title":"J. Neurochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/jnr.10672","article-title":"Citicoline decreases phospholipase A2 stimulation and hydroxyl radical generation in transient cerebral ischemia","volume":"73","author":"Adibhatla","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gandolfi, S.A., Marchini, G., Caporossi, A., Scuderi, G., Tomasso, L., and Brunoro, A. (2020). Cytidine 5\u2032-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma. Nutrients, 12.","DOI":"10.3390\/nu12030793"},{"key":"ref_19","first-page":"25","article-title":"Effects of citicholine and of the combination citicholine + piracetam on the memory (experiments on mice)","volume":"16","author":"Mosharrof","year":"1990","journal-title":"Acta Physiol. Et Pharm. Bulg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2010.07.002","article-title":"The science of stroke: Mechanisms in search of treatments","volume":"67","author":"Moskowitz","year":"2010","journal-title":"Neuron"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","article-title":"Measurements of acute cerebral infarction: A clinical examination scale","volume":"20","author":"Brott","year":"1989","journal-title":"Stroke"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/STROKEAHA.117.017866","article-title":"Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials","volume":"48","author":"Broderick","year":"2017","journal-title":"Stroke"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/jnnp.71.2.225","article-title":"The five item Barthel index","volume":"71","author":"Hobart","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-0039-1700790","article-title":"Efficacy of Neuroprotective Drugs in Acute Ischemic Stroke: Is It Helpful?","volume":"10","author":"Mehta","year":"2019","journal-title":"J. Neurosci. Rural. Pr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4103\/0028-3886.166538","article-title":"The effect of citicoline on stroke: A comparative study from the Eastern part of India","volume":"63","author":"Das","year":"2015","journal-title":"Neurol. India"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000346602","article-title":"Long-Term Treatment with Citicoline May Improve Poststroke Vascular Cognitive Impairment","volume":"35","author":"Ortega","year":"2013","journal-title":"Cereb. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1358\/mf.2010.32.5.1465004","article-title":"Citicoline for acute ischemic stroke in Mexican hospitals: A retrospective postmarketing analysis","volume":"32","author":"Chiquete","year":"2010","journal-title":"Methods Find. Exp. Clin. Pharm."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"\u00c1lvarez-Sab\u00edn, J., Santamarina, E., Maisterra, O., Jacas, C., Molina, C., and Quintana, M. (2016). Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17030390"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1358\/mf.2009.31.3.1364241","article-title":"Efficacy and safety of oral citicoline in acute ischemic stroke: Drug surveillance study in 4,191 cases","volume":"31","author":"Cho","year":"2009","journal-title":"Methods Find. Exp. Clin. Pharm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1212\/WNL.49.3.671","article-title":"A randomized dose-response trial of citicoline in acute ischemic stroke patients","volume":"49","author":"Clark","year":"1997","journal-title":"Neurology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000091547","article-title":"Citicoline in Intracerebral Haemorrhage: A Double-Blind, Randomized, Placebo-Controlled, Multi-Centre Pilot Study","volume":"21","author":"Secades","year":"2006","journal-title":"Cereb. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s11055-013-9797-x","article-title":"Neuroprotective Therapy with Citicoline (Ceraxon) in Patients with Ischemic Stroke","volume":"43","author":"Martynov","year":"2013","journal-title":"Neurosci. Behav. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.01.006","article-title":"Efficiency of Citicoline in Increasing Muscular Strength of Patients with Nontraumatic Cerebral Hemorrhage: A Double-blind Randomized Clinical Trial","volume":"17","author":"Iranmanesh","year":"2008","journal-title":"J. Stroke Cereb. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/01.STR.19.2.211","article-title":"Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study","volume":"19","author":"Tazaki","year":"1988","journal-title":"Stroke"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1179\/016164110X12807570510176","article-title":"CDP-choline treatment increases circulating endothelial progenitor cells in acute ischemic stroke","volume":"33","author":"Sobrino","year":"2011","journal-title":"Neurol. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.15407\/ubj91.05.034","article-title":"Citicoline affects serum angiostatin and neurospecific protein levels in patients with atrial fibrillation and ischemic stroke","volume":"91","author":"Tykhomyrov","year":"2019","journal-title":"Ukr. Biochem. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2058739219867244","article-title":"The cytological mechanism and effects of hypertensive cerebral hemorrhage treatment by citicoline on serum GFAP and copeptin level","volume":"17","author":"Zang","year":"2019","journal-title":"Eur. J. Inflamm."},{"key":"ref_38","first-page":"480","article-title":"The Effects of Citicoline on Cerebrovascular Hemodynamic Status in Ischemic Stroke Patients","volume":"24","author":"Seifaddini","year":"2017","journal-title":"J. Kerman Univ. Med. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.04.010","article-title":"Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Randomized, Double-Blind, and Placebo-Controlled Trials","volume":"25","author":"Secades","year":"2016","journal-title":"J. Stroke Cereb. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(12)60813-7","article-title":"Citicoline in the treatment of acute ischaemic stroke: An international, randomised, multicentre, placebo-controlled study (ICTUS trial)","volume":"380","author":"Castillo","year":"2012","journal-title":"Lancet"},{"key":"ref_41","first-page":"36","article-title":"Edaravone\u2014citicoline comparative study in acute ischemic stroke (ECCS-AIS)","volume":"60","author":"Mitta","year":"2012","journal-title":"J. Assoc. Physicians India"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1002\/sim.8278","article-title":"A parametric meta-analysis","volume":"38","author":"Yu","year":"2019","journal-title":"Stat. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1161\/01.STR.30.12.2592","article-title":"A randomized efficacy trial of citicoline in patients with acute ischemic stroke","volume":"30","author":"Clark","year":"1999","journal-title":"Stroke"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1212\/WNL.57.9.1595","article-title":"A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients","volume":"57","author":"Clark","year":"2001","journal-title":"Neurology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/1531-8249(200011)48:5<713::AID-ANA4>3.0.CO;2-#","article-title":"Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators","volume":"48","author":"Warach","year":"2000","journal-title":"Ann. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40261-016-0454-3","article-title":"The CITIRIVAD Study: CITIcoline plus RIVAstigmine in Elderly Patients Affected with Dementia Study","volume":"36","author":"Castagna","year":"2016","journal-title":"Clin. Drug Investig."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/CIA.S38420","article-title":"Effectiveness and safety of citicoline in mild vascular cognitive impairment: The IDEALE study","volume":"8","author":"Gareri","year":"2013","journal-title":"Clin. Interv. Aging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3233\/JAD-160808","article-title":"The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer\u2019s Disease Study","volume":"56","author":"Gareri","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_49","first-page":"4593","article-title":"Effect of citicoline adjuvant therapy on mild cognitive impairment in Parkinson\u2019s disease","volume":"9","author":"Zhenguang","year":"2016","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1358\/mf.1999.21.9.795632","article-title":"Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer\u2019s disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion","volume":"21","author":"Alvarez","year":"1999","journal-title":"Methods Find Exp. Clin. Pharm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archneur.1996.00550050071026","article-title":"Citicoline Improves Verbal Memory in Aging","volume":"53","author":"Spiers","year":"1996","journal-title":"Arch. Neurol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000071116","article-title":"Long-Term Citicoline (Cytidine Diphosphate Choline) Use in Patients with Vascular Dementia: Neuroimaging and Neuropsychological Outcomes","volume":"16","author":"Cohen","year":"2003","journal-title":"Cereb. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1087054715593633","article-title":"The Effect of Citicoline Supplementation on Motor Speed and Attention in Adolescent Males","volume":"23","author":"McGlade","year":"2015","journal-title":"J. Atten. Disord."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3109\/09637486.2014.940286","article-title":"Improvements in concentration, working memory and sustained attention following consumption of a natural citicoline\u2013caffeine beverage","volume":"65","author":"Bruce","year":"2014","journal-title":"Int. J. Food Sci. Nutr."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3109\/09637486.2011.632623","article-title":"Improvements in quantitative EEG following consumption of a natural citicoline-enhanced beverage","volume":"63","author":"Bruce","year":"2011","journal-title":"Int. J. Food Sci. Nutr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pbb.2015.02.004","article-title":"Neurocognitive effects of acute choline supplementation in low, medium and high performer healthy volunteers","volume":"131","author":"Knott","year":"2015","journal-title":"Pharm. Biochem. Behav."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11055-019-00883-0","article-title":"Impairments to Cognitive Control in Patients with Somatoform Disorders and Their Treatment","volume":"50","author":"Chutko","year":"2019","journal-title":"Neurosci. Behav. Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1017\/cjn.2016.290","article-title":"The International Incidence of Traumatic Brain Injury: A Systematic Review and Meta-Analysis","volume":"43","author":"Nguyen","year":"2016","journal-title":"Can. J. Neurol. Sci. J. Can. Des Sci. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00508-017-1240-9","article-title":"Citicoline in Severe Traumatic Brain Injury: Indications for Improved Outcome: A Retrospective Matched Pair Analysis From 14 Austrian Trauma Centers","volume":"130","author":"Trimmel","year":"2018","journal-title":"Wien Klin Wochenschr."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5505\/tjtes.2014.05769","article-title":"Effects of Citicoline on Level of Consciousness, Serum Level of Fetuin-A and Matrix Gla- Protein (MGP) in Trauma Patients with Diffuse Axonal Injury (DAI) and GCS \u2264 8","volume":"20","author":"Shokouhi","year":"2014","journal-title":"Turk. J. Trauma Emerg. Surg."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2012.13256","article-title":"Effect of Citicoline on Functional and Cognitive Status Among Patients With Traumatic Brain Injury","volume":"308","author":"Zafonte","year":"2012","journal-title":"JAMA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4172\/2167-1222.1000227","article-title":"Citicoline for the Treatment of Head Injury: A Systematic Review and Meta-analysis of Controlled Clinical Trials","volume":"4","author":"Secades","year":"2014","journal-title":"J. Trauma Treat."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/JPR.S70481","article-title":"Cytidine 5\u2032-diphosphocholine administration prevents peripheral neuropathic pain after sciatic nerve crush injury in rats","volume":"9","author":"Emril","year":"2016","journal-title":"J. Pain Res."},{"key":"ref_64","first-page":"54","article-title":"Investigation of the dose-dependency of citicoline effects on nerve regeneration and functional recovery in a rat model of sciatic nerve injury","volume":"24","author":"Kaplan","year":"2013","journal-title":"Turk. Neurosurg."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1179\/1743132811Y.0000000004","article-title":"CDP-choline and its endogenous metabolites, cytidine and choline, promote the nerve regeneration and improve the functional recovery of injured rat sciatic nerves","volume":"33","author":"Aslan","year":"2011","journal-title":"Neurol. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1179\/1743132812Y.0000000003","article-title":"Intraperitoneal administration of CDP-choline or a combination of cytidine plus choline improves nerve regeneration and functional recovery in a rat model of sciatic nerve injury","volume":"34","author":"Caner","year":"2012","journal-title":"Neurol. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.surneu.2006.12.054","article-title":"Citicoline improves functional recovery, promotes nerve regeneration, and reduces postoperative scarring after peripheral nerve surgery in rats","volume":"68","author":"Bekar","year":"2007","journal-title":"Surg. Neurol."},{"key":"ref_68","first-page":"1012","article-title":"Preclinical evidence for the antihyperalgesic activity of CDP-choline in oxaliplatin-induced neuropathic pain","volume":"18","author":"Kanat","year":"2013","journal-title":"J. Buon. J. Balk. Union Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/FBP.0b013e32834a1efb","article-title":"The antihyperalgesic effect of cytidine-5\u2032-diphosphate-choline in neuropathic and inflammatory pain models","volume":"22","author":"Bagdas","year":"2011","journal-title":"Behav. Pharm."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jss.2015.10.003","article-title":"CDP-choline modulates matrix metalloproteinases in rat sciatic injury","volume":"200","author":"Bekar","year":"2016","journal-title":"J. Surg. Res."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/10\/3113\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:19:52Z","timestamp":1760177992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/10\/3113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":70,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["nu12103113"],"URL":"https:\/\/doi.org\/10.3390\/nu12103113","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]}}}